Virtual Medicinal Product (VMP) - Indometacin 25mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Indometacin 25mg/5ml oral suspension | Start Date 17-11-2004 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- M01AB01
- BNF Codes
-
- BNF code 10010100
| Code | Start Date | End Date |
|---|---|---|
| 42105711000001102 | 28-07-2023 | |
| 376878007 | 16-08-2005 | 27-07-2023 |
| 8561711000001104 | 17-11-2004 | 15-08-2005 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Indometacin | Based on Ingredient Substance | 5 mg | 1 ml |
Name
Indometacin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMIndometacin
-
VMP(Current) Indometacin 25mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml | 14 | Part VIIIB |
| 100 ml | 4068 | Part VIIIB |